Testing platelet treatment in ICU patients after surgery
Part of Blood & lymphatic clinical trials.
This trial studies whether a platelet-related treatment can work better in people in the ICU who need a platelet transfusion after surgery. It may help reduce bleeding by improving how platelets work when certain blood clotting proteins are already high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You are currently an ICU patient
- You need a platelet transfusion during or after surgery
- You (or your family) can give consent, and an independent ICU doctor agrees
- You have not received Factor VIII concentrate (Haemate®) before joining the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent bleeding. If you are in the ICU with low platelets and need life support, this study may be relevant to you.
This trial tests how a platelet transfusion affects blood vessel function in intensive care patients with low platelet counts (thrombocytopenia). It may help doctors understand if transfusions help the tiny blood vessels work better.
This trial tests whether giving a platelet transfusion to patients with severe traumatic brain injury who are on antiplatelet medication can improve how well their blood clots. You may qualify if you have a serious brain bleed and are taking a medication like aspirin or clopidogrel.
This trial tests a combined approach to platelet transfusion to see if it works better. It may help patients who need platelet transfusions as part of their hospital treatment.
This study looks at whether platelet transfusions help patients with sepsis and very low platelet counts recover better. If you or your loved one had sepsis, a low platelet count, and were in the ICU for at least two days, this trial may be relevant.
This study examines how heart-lung machines used during heart surgery affect blood platelets (clotting cells) and the body's inflammatory response. Understanding these changes may help doctors better manage bleeding and inflammation after cardiac surgery.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.